Differences in management of older women influence breast cancer survival: Results from a population-based database in Sweden

被引:98
作者
Eaker, S [1 ]
Dickman, PW
Bergkvist, L
Holmberg, L
机构
[1] Univ Uppsala Hosp, Dept Surg, S-75185 Uppsala, Sweden
[2] Reg Oncol Ctr, Uppsala, Sweden
[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[4] Ctr Hosp Vasteras, Clin Res Ctr, Dept Surg, Vasteras, Sweden
来源
PLOS MEDICINE | 2006年 / 3卷 / 03期
关键词
D O I
10.1371/journal.pmed.0030025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several reports have shown that less aggressive patterns of diagnostic activity and care are provided to elderly breast carcinoma patients. We sought to investigate whether differences in the management of older women with breast cancer are associated with survival. Methods and Findings In an observational study using a population-based clinical breast cancer register of one health-care region in Sweden, we identified 9,059 women aged 50-84 y diagnosed with primary breast cancer between 1992 and 2002. The 5-y relative survival ratio was estimated for patients classified by age group, diagnostic activity, tumor characteristics, and treatment. The 5-y relative survival for breast cancer patients was lower (up to 13%) in women 70-84 y of age compared to women aged 50-69 y, and the difference was most pronounced in stage IIB-III and in the unstaged. Significant differences in disease management were found, as older women had larger tumors, had fewer nodes examined, and did not receive treatment by radiotherapy or by chemotherapy as often as the younger women. Adjustment for diagnostic activity, tumor characteristics, and treatment diminished the relative excess mortality in stages III and in the unstaged, whereas the excess mortality was only marginally affected in stage IIB. Conclusions Less diagnostic activity, less aggressive treatment, and later diagnosis in older women are associated with poorer survival. The large differences in treatment of older women are difficult to explain by co-morbidity alone.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 17 条
  • [1] Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:: The International Breast Cancer Study Group Trial VII
    Crivellari, D
    Bonetti, M
    Castiglione-Gertsch, M
    Gelber, RD
    Rudenstam, CM
    Thürlimann, B
    Price, KN
    Coates, AS
    Hürny, C
    Bernhard, J
    Lindtner, J
    Collins, J
    Senn, HJ
    Cavalli, F
    Forbes, J
    Gudgeon, A
    Simoncini, E
    Cortes-Funes, H
    Veronesi, A
    Fey, M
    Goldhirsch, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1412 - 1422
  • [2] Radiotherapy after lumpectomy for breast cancer in very old women
    Deutsch, M
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (01): : 48 - 49
  • [3] Tumor characteristics and clinical outcome of elderly women with breast cancer
    Diab, SG
    Elledge, RM
    Clark, GM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) : 550 - 556
  • [4] Regression models for relative survival
    Dickman, PW
    Sloggett, A
    Hills, M
    Hakulinen, T
    [J]. STATISTICS IN MEDICINE, 2004, 23 (01) : 51 - 64
  • [5] Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer
    Du, XLL
    Key, CR
    Osborne, C
    Mahnken, JD
    Goodwin, JS
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (02) : 90 - 97
  • [6] EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101
  • [7] Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    Fyles, AW
    McCready, DR
    Manchul, LA
    Trudeau, ME
    Merante, P
    Pintilie, M
    Weir, LM
    Olivotto, IA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (10) : 963 - 970
  • [8] Breast cancer treatment guidelines in older women
    Giordano, SH
    Hortobagyi, GN
    Kau, SWC
    Theriault, RL
    Bondy, ML
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 783 - 791
  • [9] Hebert-Croteau N, 1999, CANCER-AM CANCER SOC, V85, P1104, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1104::AID-CNCR14>3.0.CO
  • [10] 2-1